NCT00766935View on ClinicalTrials.gov

The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions
Lymphedema
Trial Locations (1)

4032

Queensland Lymphoedema and Breast Oncology Physiotherapy, Brisbane

All Listed Sponsors
lead

ImpediMed Limited

INDUSTRY

NCT00766935 - The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device | Biotech Hunter | Biotech Hunter